Application Notes & Case Studies

  1. Precision Polymorph Screening With Electron Diffraction 5/6/2026

    See how polymorph screening with electron diffraction uncovers hidden forms, enabling precise identification and reliable quantification of minor phases affecting performance and manufacturability.

  2. De-Risking Drug Development: Informatics-Supported Solid Form Selection 5/6/2026

    Learn how combining polymorph screening with structural informatics improves solid‑form selection, lowers development risk, and boosts confidence in long‑term stability and manufacturability.

  3. Mechanochemistry- Enabled Solid-State Stress Testing 5/6/2026

    Discover how solvent‑free, solid‑state stress testing speeds degradation studies, yields realistic impurity profiles, and provides earlier, material‑efficient insight into drug stability and risk.

  4. High Drug Tolerance ADA Testing For Long‑Acting mAbs 5/6/2026

    See how advanced ADA assay design overcomes extreme drug interference, enabling reliable immunogenicity assessment for long‑acting, high‑dose monoclonal antibodies in early clinical development.

  5. Enabling Complex Phase IIa Dosing Through Flexible Clinical Packaging Design 5/6/2026

    Discover how flexible, patient‑centric clinical packaging supports complex Phase IIa dosing while protecting timelines, ensuring compliance, and avoiding costly primary packaging changes.

  6. Rapid Selection Of High-Performance CHO Basal And Feed Media 5/5/2026

    A CHO-S bispecific antibody program needed a better basal and feed media combination. Learn how the screening of 180 conditions in 12 weeks identified one that delivered 38% higher titers.

  7. Successful Tech Transfer Meets Commercial Needs 5/5/2026

    An accelerated technology transfer reduced time to PPQ by over 25%, overcoming novel raw materials, unique IP constraints, and late‑stage process optimization to meet urgent commercial demand.

  8. Formulation & Delivery Of Spray Dried Biologics For Nasal Dosage Forms 4/27/2026

    Spray drying enables stable, scalable dry‑powder nasal biologics, improving shelf life, particle control, and targeted delivery for peptides, proteins, vaccines, and oligonucleotides.

  9. Stability With IDBS Polar 4/24/2026

    Manual tracking often leads to missed pulls and data gaps. Discover how a connected digital workflow governs stability execution, ensuring consistency and regulatory confidence at every timepoint.

  10. Achieving High Cell Purity With The CTS DynaCellect Magnetic Separation System 4/21/2026

    Learn how closed-system automation, combined with expert technical guidance and protocol optimization, turned a persistent manufacturing bottleneck into a reliable, scalable process.